Vallon Pharmaceuticals, Inc. Business Finance Contracts & Agreements
53 Contracts & Agreements
- Assignment Agreements (1 contract)
- Investor Rights Agreements (1)
- Note Agreements (5)
- Purchase Agreements (7)
- Stock Agreements (16)
- Subscription Agreements (1)
- Underwriting Agreements (2)
- Warrant Agreements (20)
- Form of Securities Purchase Agreement, dated as of February 1, 2024, between GRI Bio, Inc. and each purchaser named in the signature pages thereto (Filed With SEC on February 2, 2024)
- Form of Series B-2 Common Warrant (Filed With SEC on February 2, 2024)
- Form of Series B-1 Common Warrant (Filed With SEC on February 2, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on February 2, 2024)
- Form of Securities Purchase Agreement (Filed With SEC on January 31, 2024)
- Form of Series B-2 Common Warrant (Filed With SEC on January 31, 2024)
- Form of Series B-1 Common Warrant (Filed With SEC on January 31, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on January 31, 2024)
- Asset Purchase Agreement, dated as of August 22, 2023, by and between GRI Bio, Inc. and Aardvark Therapeutics, Inc (Filed With SEC on August 23, 2023)
- Form of Ecoban Warrant (Filed With SEC on April 21, 2023)
- Omnibus Amendment to Securities Purchase Agreements, dated February 17, 2023, by and among Vallon Pharmaceuticals, Inc., GRI Bio, Inc. and the investor party thereto (Filed With SEC on February 24, 2023)
- Stock Redemption Agreement, by and between GRI Bio, Inc. and Catalent Ontario Limited, dated as of November 2 (Filed With SEC on December 23, 2022)
- Restricted Stock Award Agreement, by and between GRI Bio, Inc. and W. Marc Hertz, dated as of December (Filed With SEC on December 23, 2022)
- Restricted Stock Award Agreement, by and between GRI Bio, Inc. and W. Marc Hertz, dated as of March 31 (Filed With SEC on December 23, 2022)
- Restricted Stock Award Agreement, by and between GRI Bio, Inc. and W. Marc Hertz, dated as of April 2, 2015, as amended by the Amendment to the Restricted Stock Award Agreement,... (Filed With SEC on December 23, 2022)
- Restricted Stock Purchase Agreement, by and between GRI Bio, Inc. and W. Marc Hertz, dated as of March 28 (Filed With SEC on December 23, 2022)
- Restricted Stock Award Agreement, by and between GRI Bio, Inc. and Sean Edwards, dated as of December (Filed With SEC on December 23, 2022)
- Restricted Stock Award Agreement, by and between GRI Bio, Inc. and Sean Edwards, dated as of March 31 (Filed With SEC on December 23, 2022)
- Restricted Stock Award Agreement, by and between GRI Bio, Inc. and Vipin Kumar Chaturvedi, dated as of April 2, 2015, as amended by the Amendment to the Restricted Stock Award... (Filed With SEC on December 23, 2022)
- Restricted Stock Purchase Agreement, by and between GRI Bio, Inc. and Vipin Kumar Chaturvedi, dated as of March 28 (Filed With SEC on December 23, 2022)
- Restricted Stock Award Agreement, by and between GRI Bio, Inc. and Albert Agro, dated as of April 2, 2015, as amended by the Amendment to the Restricted Stock Award Agreement, by... (Filed With SEC on December 23, 2022)
- Restricted Stock Purchase Agreement, by and between GRI Bio, Inc. and Albert Agro, dated as of November 1 (Filed With SEC on December 23, 2022)
- Nonqualified Stock Option Agreement by and between GRI Bio, Inc. and Gerald Yakatan, dated as of November 4 (Filed With SEC on December 23, 2022)
- Nonqualified Stock Option Agreement by and between GRI Bio, Inc. and Rohit Loomba, dated as of November 4 (Filed With SEC on December 23, 2022)
- Warrant to Purchase Stock issued to FT618 Investments, LLC, dated as of December 28, 2020 (Filed With SEC on December 23, 2022)
- Warrant to Purchase Stock issued to FT618 Investments, LLC, dated as of November 9, 2020 (Filed With SEC on December 23, 2022)
- Warrant to Purchase Stock issued to Eric Reiter, dated as of November 4, 2020 (Filed With SEC on December 23, 2022)
- Warrant to Purchase Stock issued to Dinver LLC, dated as of November 4, 2020 (Filed With SEC on December 23, 2022)
- Warrant to Purchase Stock issued to Oppel Greeff, dated as of November 4, 2020 (Filed With SEC on December 23, 2022)
- Warrant to Purchase Stock issued to Oppel Greeff, dated as of July 7, 2022 (Filed With SEC on December 23, 2022)
- Warrant to Purchase Stock issued to TEP Biotech, LLC, dated as of July 7, 2022 (Filed With SEC on December 23, 2022)
- Warrant to Purchase Stock issued to TEP Biotech, LLC, dated as of December 3, 2019 (Filed With SEC on December 23, 2022)
- Warrant to Purchase Stock issued to TEP Biotech, LLC, dated as of November 2, 2018 (Filed With SEC on December 23, 2022)
- Form of Senior Secured Note of GRI Bio, Inc (Filed With SEC on December 23, 2022)
- Form of Amendment No. 1 to Common Stock Purchase Warrant (Filed With SEC on July 26, 2022)
- Amendment No. 1 to Securities Purchase Agreement dated July 25, 2022 (Filed With SEC on July 26, 2022)
- Form of Securities Purchase Agreement (Filed With SEC on May 13, 2022)
- Form of Warrant (Filed With SEC on May 13, 2022)
- Form of Representatives Warrant (Filed With SEC on February 16, 2021)
- Underwriting Agreement, dated February 9, 2021, between the Company and ThinkEquity, a division of Fordham Financial Management, Inc (Filed With SEC on February 16, 2021)